• East-West Biopharma Summit Road Trip: New York--Boston--San Diego--Silicon Valley, Oct 20, Boston, US
• Bio-Europe 2022, Oct. 24-26, Leipzig, DE
• BioCentury- BayHelix East-West Biopharma Summit, Nov. 14-18, San Francisco, US

SHANGHAI, China -- NeuShen Therapeutics, Inc., a biotechnology company focusing on developing innovative treatments for central nervous system (CNS) disorders with dual platforms of AAV-based gene therapy and small molecule discovery, announced today the participation of following conferences:

East-West Biopharma Summit Road Trip: New York--Boston--San Diego--Silicon Valley, Oct 20, Boston, US, Dr. Joan Shen, Founder and CEO
Panel: Biotech Company's Opportunity during this Winter

Bio-Europe 2022, Oct. 24-26, Leipzig, DE, Dr. Joan Shen, Founder and CEO
One on one group meeting open to schedule for discussing potential collaboration and financing.

BioCentury- BayHelix East-West Biopharma Summit, Nov. 14-18, San Francisco, US, Dr. Joan Shen, Founder and CEO
Present on Strategy Workshop: Planting Footprints Abroad on Wednesday, Nov 16.

About NeuShen Therapeutics

NeuShen Therapeutics is a biotechnology company focusing on innovative drug research and development to address CNS disorders, applying dual research platforms, including AAV-based gene therapy and small molecule discovery. With operations both in Shanghai, China and Boston, MA, NeuShen has a world-class team and is honored to be advised by an outstanding Board of Directors and Scientific Advisory Board.